Funding for this research was provided by:
National Institute on Drug Abuse (T32 DA007294, K24 DA022412, T32 DA007294)
Article History
First Online: 6 May 2019
Compliance with Ethical Standards
:
: Matisyahu Shulman and Jonathan M. Wai were funded by the National Institute on Drug Abuse Grant T32 DA007294. Edward V. Nunes was funded by the National Institute on Drug Abuse Grant K24 DA022412 (PI: Nunes). The authors alone are responsible for the content and writing of this article. Manuscript preparation and the decision to submit the manuscript for publication were the sole responsibilities of the authors.
: Edward V. Nunes has served as an investigator on clinical trials for which Reckitt Benckiser Inc. supplied Suboxone, and for which Alkermes, Inc. supplied Vivitrol for study medication, and has served as a consultant without compensation on advisory boards to Alkermes, Inc. Matisyahu Shulman and Jonathan M. Wai have no conflicts of interest that are directly relevant to the content of this article.